prodchem
Aug 12, 2026
The global chemical industry entered 2026 under pressure from weak industrial demand, excess capacity, high energy costs, and volatile commodity markets. Yet beneath the difficult headline numbers, several chemical companies are showing signs of improvement in cash generation, working-capital discipline, and balance-sheet management.
This makes cash flow one of the most useful indicators for identifying potential turnaround stories. Earnings can improve because of accounting effects, pricing changes, or inventory movements, but sustained free cash flow generally requires stronger underlying operating performance and tighter control over capital expenditure and working capital.
Based on developments visible through 2026, several companies stand out as notable cash-flow turnaround candidates.
Omnia stands out as one of the clearest long-term chemical-sector turnaround stories.
The South African chemicals and fertilizer group entered a severe financial situation several years ago, with heavy debt and significant pressure on its balance sheet. Since then, management has undertaken a major restructuring and focused on improving operational efficiency and reducing financial leverage.
The turnaround has been substantial. A 2026 review described Omnia as one of the Johannesburg Stock Exchange's strongest turnaround stories, noting that the company had moved from a highly leveraged position toward a significantly healthier financial structure.
Its importance as a cash-flow story comes from the combination of debt reduction, stronger operating performance, and improved capital discipline.
Significant balance-sheet repair
Better operating efficiency
Reduced financial pressure
Stronger cash generation
Exposure to agriculture and mining markets
Omnia demonstrates that a chemical company can rebuild cash generation even after a severe balance-sheet crisis.
India's Sudarshan Chemical Industries provides another interesting example.
The company has been integrating the acquired Heubach pigment operations, creating both significant execution risks and opportunities for efficiency improvements.
By the end of FY26, signs of improvement were becoming visible. Business EBITDA for the acquired group reached €11 million in Q4, ahead of the company's projected €9 million–€10 million range. More importantly from a cash-flow perspective, inventory reduction reached €29 million, compared with a planned €20 million.
Net debt also declined from approximately ₹934 crore in December 2025 to ₹755 crore in March 2026.
The reduction in inventory and debt shows that the turnaround is not purely an earnings story. Working-capital release is directly supporting the balance sheet.
Sudarshan therefore represents a potentially important cash-conversion turnaround, although integration execution remains a key risk.
Germany's Evonik is another company showing encouraging signs.
The company raised its 2026 adjusted EBITDA outlook after second-quarter performance came in ahead of expectations. More importantly for a cash-flow ranking, Evonik said its second-quarter free cash flow was expected to be significantly better than the previous year's negative €211 million.
The company continues to target a cash-conversion rate of around 40%, compared with 37% in 2025.
This suggests that management is focusing not only on improving profitability but also on converting earnings into actual cash.
Better working-capital management
Cost reductions
Improved margins
Disciplined capital expenditure
Portfolio optimization
However, Evonik remains exposed to the difficult European chemical environment, so sustained cash-flow improvement will depend on whether stronger margins persist.
Lotte Chemical Pakistan has also shown a notable improvement in financial performance during 2026.
The company more than doubled quarterly earnings in the first quarter, with profit after tax increasing 123% year on year to Rs1.5 billion despite revenue declining slightly.
The recovery was primarily margin-driven. Gross profit increased approximately 120% year on year, while gross margin expanded from 6.2% to 14.0%.
This is relevant to a cash-flow turnaround because stronger margins can improve operating cash generation even without substantial revenue growth.
However, the company continues to face feedstock-supply constraints and relies on alternative paraxylene sourcing, meaning its cash performance remains sensitive to raw-material availability and pricing.
India's specialty-chemicals sector is also showing early signs of recovery.
A 2026 sector review highlighted improving pricing conditions for several products, including vitamin B3 and acetic acid, alongside new capacity and CDMO opportunities.
For Jubilant Ingrevia, the recovery in pricing and the planned ramp-up of an agro-CDMO facility provide potential support for stronger future margins and cash generation.
The company therefore represents more of an emerging cash-flow turnaround than a completed one.
The key question is whether improved pricing and new specialty capacity translate into sustained operating cash flow as the new assets ramp up.
Dow presents a different type of cash-flow story.
The company remains exposed to weak global chemical demand and significant capital requirements, making free cash flow an important metric for investors.
Dow defines free cash flow as cash generated from operating activities after capital expenditures. Its second-quarter 2026 results continue to make cash generation an important indicator of how successfully the company is navigating the current cycle.
Dow is therefore less of a straightforward turnaround than Omnia or Sudarshan, but its ability to stabilize cash generation during a difficult chemical cycle could become an important signal for the broader industry.
Rank | Company | Cash-Flow Turnaround Signal | Key Driver |
|---|---|---|---|
1 | Omnia | Strong | Debt reduction and operational turnaround |
2 | Sudarshan Chemical | Strong | Inventory reduction and lower net debt |
3 | Evonik | Improving | Better free cash flow and cash conversion |
4 | Lotte Chemical Pakistan | Improving | Margin recovery |
5 | Jubilant Ingrevia | Emerging | Specialty pricing and CDMO expansion |
6 | Dow | Watchlist | Cash discipline through the cycle |
The chemical industry provides a good example of why investors and procurement professionals should look beyond reported earnings.
A company can report higher profits while still experiencing weak cash generation if:
Inventory increases
Customers delay payments
Capital expenditure rises
Working capital absorbs cash
Restructuring costs increase
Raw-material prices rise faster than selling prices
Conversely, a company can generate strong cash even when revenue growth is limited if it reduces inventories, collects receivables faster, improves margins, or reduces capital expenditure.
This makes free cash flow and working-capital movements particularly valuable indicators during an industry downturn.
Working capital is becoming one of the most important tools in the chemical-sector recovery.
When demand is weak, producers often accumulate inventory because they cannot adjust production quickly enough. Reducing those inventories can release substantial amounts of cash.
Sudarshan's 2026 experience illustrates this point particularly well. Its inventory reduction exceeded its original target while net debt also declined.
For chemical companies, therefore, the cash-flow turnaround can begin before the revenue turnaround.
Several factors are supporting cash-flow improvements across selected chemical companies.
Companies are cutting operating expenses and restructuring production networks to protect margins.
Lower inventories can release cash and reduce financing requirements.
Producers are increasingly shutting or idling uneconomic facilities rather than continuing to consume cash.
Certain specialty-chemical markets are beginning to recover from severe pricing pressure.
Companies are becoming more selective about new investments and prioritizing projects with clearer returns.
The biggest risk is assuming that every improvement represents a sustainable turnaround.
The global chemical sector continues to face substantial structural challenges. European producers remain under pressure from high energy costs and competition from lower-cost Asian production.
Recent market developments show that geopolitical disruptions can temporarily improve chemical margins by restricting supply, but such improvements may disappear once supply chains normalize.
Therefore, companies with genuine improvements in cash conversion, debt reduction, and operating efficiency are likely to be more resilient than those relying primarily on temporary price movements.
The chemical industry's cash-flow recovery is likely to remain highly selective.
The strongest turnaround stories will probably be companies that can demonstrate three things simultaneously:
Higher operating cash generation
Lower working-capital requirements
Sustainable balance-sheet improvement
Omnia and Sudarshan currently provide particularly strong examples of this combination, while Evonik offers a larger European example of improving free-cash-flow conversion.
Meanwhile, companies such as Lotte Chemical Pakistan and Jubilant Ingrevia could become stronger turnaround candidates if improved margins translate into sustained cash generation.
2026 is shaping up to be a year in which cash flow matters more than headline earnings across the chemical sector.
The industry's recovery remains uneven, but several companies are showing meaningful improvements in working-capital management, debt reduction, margins, and free cash flow.
Omnia currently stands out as one of the strongest long-term turnaround stories, while Sudarshan Chemical is demonstrating how inventory reduction and integration can improve cash generation. Evonik provides evidence of improving free cash flow in Europe's difficult chemical market, while Lotte Chemical Pakistan and Jubilant Ingrevia represent emerging recovery stories.
For investors, lenders, and chemical-market participants, the key question is increasingly simple: which companies are actually converting operational improvements into cash?
That distinction could determine which chemical-sector recovery stories become sustainable turnarounds—and which remain temporary rebounds.
Featured Product
Found this useful?
Continue Reading
Mosaic's lower Q2 2026 SG&A expenses partly reflect reduced bad debt costs, highlighting the importance of credit management and disciplined overhead control across the fertilizer industry
The contrast between Albemarle's 155% EBITDA surge and Mosaic's swing to a net loss ranks among the sharpest single-week earnings divergences of the 2026
The Quaker Houghton Q2 2026 earnings release schedule gives chemical buyers and industrial procurement teams a useful point for tracking company performance. Here is why the announcement matters for market participants watching industrial chemical demand, supply conditions and purchasing decisions.
